Acute pancreatitis: Molecular biology update

Journal of Gastrointestinal Surgery

Volumn 7, Issue 8, 2003, Pages 940-942

  Whitcomb, David C ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; TRYPSIN; TRYPSINOGEN;

ACUTE PANCREATITIS; CALCIUM BINDING; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENETIC DISORDER; HUMAN; HYDROLYSIS; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; PANCREAS FUNCTION; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 0346850749     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2003.10.001     Document Type: Conference Paper

References (16)

1. Rinderknecht H. Pancreatic secretory enzymes. Go V.L.W., DiMagno E.P., Gardner J.D., Lebenthal E., Reber H.A., Scheele G.A. The Pancreas: Biology, Pathobiology, and Disease. 2nd ed :1993;219-251 Raven Press, New York.
2. Wang Y., Prpic V., Green G.M., Reeve J.R. Jr., Liddle R.A. Luminal CCK-releasing factor stimulates CCK release from human intestinal endocrine and STC-1 cells. Am J Physiol Gastrointest Liver Physiol. 282:2002;G16-G22.
3. Whitcomb D.C. Early trypsinogen activation in acute pancreatitis. Gastroenterology. 116:1999;770-773.
4. Fernandez-del Castillo C., Schmidt J., Warshaw A.L., Rattner D.W. Interstitial protease activation is the central event in progression to necrotizing pancreatitis. Surgery. 116:1994;497-504.
5. Cavallini G., Tittobello A., Frulloni L., Masci E., Mariana A., Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med. 335:1996;919-923.
6. Whitcomb D.C., Gorry M.C., Preston R.A., et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 14:1996;141-145.
7. Whitcomb D.C. Genetic predispositions to acute and chronic pancreatitis. Med Clin North Am. 84:2000;531-547.
8. Neoptolemos J.P., Kemppainen E.A., Mayer J.M., et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: A multicentre study. Lancet. 355:2000;1955-1960.
9. Whitcomb D.C. How to think about SPINK and pancreatitis. Am J Gastroenterol. 97:2002;1085-1088.
10. Colomb E., Guy O., Deprez P., Michel R., Figarella C. The two human trypsinogens: Catalytic properties of the corresponding trypsins. Biochem Biophys Acta. 525:1978;186-193.
11. Simon P., Weiss F.U., Sahin-Toth M., et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122uCys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem. 277:2002;5404-5410.
12. Frick T.W., Fernandez-del Castillo C., Bimmler D., Warshaw A.L. Elevated calcium and activation of trypsinogen in rat pancreatic acini. Gut. 41:1997;339-343.
13. Mithofer K., Fernandez-del Castillo C., Frick T.W., Lewandrowski K.B., Rattner D.W., Warshaw A.L. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology. 109:1995;239-246.
14. Voronina S., Longbottom R., Sutton R., Petersen O.H., Tepikin A. Bile acids induce calcium signals in mouse pancreatic acinar cells: Implications for bile-induced pancreatic pathology. J Physiol. 540:(Pt 1):2002;49-55.
15. Cohn J.A., Friedman K.J., Noone P.G., Knowles M.R., Silverman L.M., Jowell P.S. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 339:1998;653-658.
16. Sharer N., Schwarz M., Malone G., et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 339:1998;645-652.